These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16689711)

  • 21. The role of economic appraisal in Denmark.
    Alban A
    Soc Sci Med; 1994 Jun; 38(12):1647-52. PubMed ID: 8047923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal.
    Thakkar V; Sullivan T
    Int J Health Policy Manag; 2017 Nov; 6(11):617-620. PubMed ID: 29179288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.
    Gafni A
    Am J Manag Care; 1997 May; 3 Suppl():S21-32. PubMed ID: 10180338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revolution then evolution: the advance of health economic evaluation in Australia.
    Lopert R; Viney R
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):360-6. PubMed ID: 25444293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health economic evaluation: important principles and methodology.
    Rudmik L; Drummond M
    Laryngoscope; 2013 Jun; 123(6):1341-7. PubMed ID: 23483522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twenty years of health care economic analysis in Spain: are we doing well?
    García-Altés A
    Health Econ; 2001 Dec; 10(8):715-29. PubMed ID: 11747053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Hanover Consensus: helpful for German decision-makers?
    Kolominsky-Rabas PL; Caro JJ
    Value Health; 2008; 11(4):545-6; discussion 547-8. PubMed ID: 18489522
    [No Abstract]   [Full Text] [Related]  

  • 29. A difficult balancing act: policy actors' perspectives on using economic evaluation to inform health-care coverage decisions under the Universal Health Insurance Coverage scheme in Thailand.
    Teerawattananon Y; Russell S
    Value Health; 2008 Mar; 11 Suppl 1():S52-60. PubMed ID: 18387068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health economics. A bridge over troubled water.
    Brouwer WB; Rutten FF
    Eur J Public Health; 2001 Jun; 11(2):234-6. PubMed ID: 11420818
    [No Abstract]   [Full Text] [Related]  

  • 31. Quality of life and health economics: where is the link?
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 221():33-6. PubMed ID: 9110396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative health systems. Switzerland.
    Zweifel P
    Adv Health Econ Health Serv Res Suppl; 1990; 1():77-101. PubMed ID: 10113796
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness ratios: in a league of their own.
    Birch S; Gafni A
    Health Policy; 1994 May; 28(2):133-41. PubMed ID: 10136058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health services research clinical trials: issues in the evaluation of economic costs and benefits.
    Manheim LM
    Control Clin Trials; 1998 Apr; 19(2):149-58. PubMed ID: 9551279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2012 ISMRM Lauterbur Lecture. MRI: from science to society.
    Lee VS
    J Magn Reson Imaging; 2013 Apr; 37(4):753-60. PubMed ID: 23441004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [German recommendations for health care economic evaluation studies. Revised version of the Hannover consensus. Hannover Consensus Group].
    Med Klin (Munich); 2000 Jan; 95(1):52-5. PubMed ID: 10668346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term care research and policy.
    Kemper P
    Gerontologist; 2003 Aug; 43(4):436-46. PubMed ID: 12937323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.
    Lee KS; Brouwer WB; Lee SI; Koo HW
    Pharmacoeconomics; 2005; 23(7):709-21. PubMed ID: 15987227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative dynamic analysis of the full Grossman model.
    Ried W
    J Health Econ; 1998 Aug; 17(4):383-425. PubMed ID: 10180925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. What constitutes a useful economic study? The health systems perspective.
    Lee TH
    Am Heart J; 1999 May; 137(5):S67-70. PubMed ID: 10220600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.